compliance
Agency maintains its hard-line stance on coronavirus-related claims
By: David Rauf
“It almost seems like what the FTC is saying is you can’t represent that you have a business opportunity.”
—Michael Collins, President and CEO, M&L Collins Group
“The FTC is going to be very diligent. We’re not going to tolerate these claims.”
—Lois Greisman, Assoc. Director of Marketing Practices, Federal Trade Commission
The Federal Trade Commission (FTC) has issued warning letters to six more direct selling companies over alleged misleading product and earnings claims related to the coronavirus. This represents the latest escalation between regulators and the direct selling channel over how to market products and business opportunities during the ongoing pandemic.
Attorneys provide answers on topics ranging from marketing to compliance
By: John Sanders, Katrina Eash and Rebecca Loegering from Winston & Strawn
Ensuring that compliance permeates all aspects of a business’s operation will certainly serve the long-term interests of a company by keeping it off the radar of regulators.
Editor’s Note: The attorneys at Winston & Strawn have provided answers to the most common questions they’ve been asked about direct selling business practices by their clients during the COVID-19 pandemic. In the article below they share their insights and opinions.
Her thoughts on credibility, scientific substantiation and compliance.
Founded: 1987
Executive: Asma Ishaq
Location: Springville, UT
Website: www.modere.com
This month, SSN interviewed Asma Ishaq, CEO of health, wellness and household care company Modere. Ishaq entered the direct selling channel in 2009 as a co-founder at Jusuru International. In 2017, Modere purchased Jusuru from Ishaq and launched its Collagen Sciences division, which Ishaq came on board to run. She was promoted to CEO of Modere in January. 2018.